352 related articles for article (PubMed ID: 16630079)
1. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
[TBL] [Abstract][Full Text] [Related]
2. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.
Paquet P; Jacob E; Damas P; Pirson J; Piérard G
Arch Dermatol Res; 2005 Dec; 297(6):266-73. PubMed ID: 16249890
[TBL] [Abstract][Full Text] [Related]
3. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis.
Paquet P; Ribbens C; Piérard GE
Clin Exp Dermatol; 2007 Nov; 32(6):728-32. PubMed ID: 17714530
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
5. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.
Al-Mutairi N; Arun J; Osama NE; Amr Z; Mazen AS; Ibtesam el-A; Nazeha el-B
Int J Dermatol; 2004 Nov; 43(11):847-51. PubMed ID: 15533072
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
Chen J; Wang B; Zeng Y; Xu H
Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
[TBL] [Abstract][Full Text] [Related]
7. Functionally active macrophage-derived myeloperoxidase in the skin of drug-induced toxic epidermal necrolysis.
Paquet P; De Groote D; Piérard GE
Dermatology; 2010; 220(3):201-7. PubMed ID: 20332596
[TBL] [Abstract][Full Text] [Related]
8. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
Sidwell RU; Swift S; Yan CL; Porter W; Thompson EM; Clark JA; Bunker CB
Int J Clin Pract; 2003 Sep; 57(7):643-5. PubMed ID: 14529073
[TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.
Yip LW; Thong BY; Tan AW; Khin LW; Chng HH; Heng WJ
Eye (Lond); 2005 Aug; 19(8):846-53. PubMed ID: 15389280
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of toxic epidermal necrolysis treated with human intravenous immunoglobulin.
Romanelli P; Schlam E; Green JB; Trent JT; Ricotti C; Elgart GW; Kirsner RS; Kerdel FA
G Ital Dermatol Venereol; 2008 Aug; 143(4):229-33. PubMed ID: 18833079
[TBL] [Abstract][Full Text] [Related]
11. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
French LE; Trent JT; Kerdel FA
Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
[TBL] [Abstract][Full Text] [Related]
12. Toxic epidermal necrolysis and intravenous immunoglobulin: a review.
Trent J; Halem M; French LE; Kerdel F
Semin Cutan Med Surg; 2006 Jun; 25(2):91-3. PubMed ID: 16908399
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Khalili B; Bahna SL
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
[TBL] [Abstract][Full Text] [Related]
14. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
[TBL] [Abstract][Full Text] [Related]
15. Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin.
Mayorga C; Torres MJ; Corzo JL; Sanchez-Sabate E; Alvarez J; Vera A; Posadas S; Jurado A; Blanca M
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):86-91. PubMed ID: 12877456
[TBL] [Abstract][Full Text] [Related]
16. IVIG for the treatment of toxic epidermal necrolysis.
Mittmann N; Chan BC; Knowles S; Shear NH
Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
Teo L; Tay YK; Liu TT; Kwok C
Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of immunoglobulins and of antibody isotypes in bone marrow transplant recipients treated with high doses of polyspecific immunoglobulin or with cytomegalovirus hyperimmune globulin.
Gratwohl A; Doran JE; Bachmann P; Scherz R; Späth P; Baumgartner C; Perret B; Berger C; Nissen C; Tichelli A
Bone Marrow Transplant; 1991 Oct; 8(4):275-82. PubMed ID: 1661632
[TBL] [Abstract][Full Text] [Related]
19. Treatment of toxic epidermal necrolysis (TEN) with low dose intravenous immunoglobulin in child.
Habib A; Pasha W; Raza N
J Coll Physicians Surg Pak; 2010 Mar; 20(3):205-7. PubMed ID: 20392387
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report.
Lissia M; Figus A; Rubino C
Br J Plast Surg; 2005 Jun; 58(4):504-10. PubMed ID: 15897036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
